GO:1904479 negative regulation of intestinal absorption: Regulatory Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904479 (negative regulation of intestinal absorption) describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of intestinal absorption.
• Intestinal absorption is the primary route for uptake of water-soluble vitamins, iron, calcium, and dietary lipids; its negative regulation is critical for preventing overload toxicity and maintaining systemic homeostasis.
• Key regulatory nodes include iron-regulatory proteins (IRP1/IRP2), the hormone hepcidin (HAMP), calcium-sensing receptor (CASR), and vitamin transporters such as SLC19A1 and SLC23A1.
• Dysregulation of negative regulation of intestinal absorption contributes to iron overload disorders, hypercalcemia, vitamin deficiencies, and metabolic-associated fatty liver disease (MAFLD).
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes that negatively regulate intestinal absorption.
• EDITGENE provides end-to-end CRISPR services including library screening and bioinformatics to accelerate research on GO:1904479-related pathways.
Description
Intestinal absorption is the process by which nutrients, vitamins, minerals, and other molecules are taken up from the gut lumen into the bloodstream. The Gene Ontology term GO:1904479, negative regulation of intestinal absorption, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of this absorption. This regulatory process is essential for preventing excessive accumulation of potentially toxic substances such as iron and calcium, and for maintaining systemic homeostasis. Researchers study GO:1904479 to understand how the body balances nutrient uptake with demand, and how this balance is disrupted in disease. For example, the iron-regulatory hormone hepcidin (HAMP) negatively regulates intestinal iron absorption by degrading the exporter ferroportin (SLC40A1), thereby limiting iron entry into the circulation. Similarly, the calcium-sensing receptor (CASR) in the gut can inhibit calcium absorption when systemic calcium levels are sufficient. These examples illustrate that negative regulation of intestinal absorption is not a single pathway but a network of molecular sensors and effectors that respond to systemic needs. Understanding this network has broad implications for treating iron overload, hypercalcemia, vitamin toxicities, and metabolic disorders. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1904479, its mechanisms, key genes, disease relevance, and experimental models.
negative regulation of intestinal absorption At A Glance
| GO ID | GO:1904479 |
|---|---|
| GO term | negative regulation of intestinal absorption |
| Ontology | biological_process |
| Synonym | down regulation of intestinal absorption; down-regulation of intestinal absorption; downregulation of intestinal absorption; inhibition of intestinal absorption |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of intestinal absorption |
| Related processes | Iron homeostasis, calcium homeostasis, vitamin uptake, lipid absorption |
| Key regulators | HAMP, SLC40A1, CASR, IRP1 (ACO1), IRP2 (IREB2), SLC19A1, SLC23A1 |
| Disease relevance | Iron overload, hypercalcemia, vitamin deficiencies, metabolic-associated fatty liver disease |
What Is GO:1904479?
According to the Gene Ontology, GO:1904479 (negative regulation of intestinal absorption) is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of intestinal absorption. In other words, it includes molecular events that dampen the uptake of nutrients, vitamins, minerals, or other substances from the intestinal lumen into the body. This term is a biological process and is synonymous with down regulation, down-regulation, downregulation, or inhibition of intestinal absorption.
Why Is negative regulation of intestinal absorption Important in Cell Biology?
Negative regulation of intestinal absorption is vital because uncontrolled uptake of nutrients and minerals can lead to toxicity and disease. For instance, excessive iron absorption causes iron overload, which damages the liver, heart, and endocrine organs. Conversely, failure to negatively regulate calcium absorption can result in hypercalcemia, affecting renal and neuromuscular function. The process also impacts vitamin homeostasis; water-soluble vitamins such as folate and ascorbate are absorbed via specific transporters that can be downregulated to prevent oversaturation. Moreover, recent evidence links intestinal lipid absorption to immune responses, highlighting broader physiological roles. Understanding GO:1904479 therefore provides insights into homeostatic control and offers therapeutic targets for disorders of nutrient overload.
• Prevents iron overload by limiting dietary iron uptake via hepcidin-ferroportin axis.
• Protects against hypercalcemia by reducing calcium absorption when systemic calcium is high.
• Maintains vitamin homeostasis by downregulating transporters for water-soluble vitamins.
• Modulates dietary lipid absorption, influencing metabolic and immune responses.
• Dysregulation contributes to metabolic-associated fatty liver disease (MAFLD).
• Provides therapeutic targets for iron chelation and calcium management.
• Involved in drug-nutrient interactions, e.g., niacinamide effects on intestinal absorption.
• Key to understanding gut microbiome-host interactions in nutrient handling.
• Relevant to cancer cachexia and malnutrition via altered nutrient uptake.
• Offers experimental tractability through CRISPR screens and transporter assays.
What Happens During negative regulation of intestinal absorption?
Sensing of systemic nutrient status
In simple terms: The body first checks whether it has enough of a nutrient before deciding to absorb more.
Negative regulation of intestinal absorption begins with sensors that detect systemic levels of nutrients or minerals. For iron, the liver-derived hormone hepcidin (HAMP) responds to iron stores and inflammation; when iron is sufficient, hepcidin is produced and secreted into the bloodstream. For calcium, the calcium-sensing receptor (CASR) on intestinal cells and other tissues detects extracellular calcium concentrations. These sensors integrate signals from the diet and body stores to determine whether absorption should be reduced.
Downregulation of apical transporters
In simple terms: The proteins that pull nutrients into the gut cells are turned down or removed.
Once a signal for negative regulation is received, the expression or activity of apical transporters is reduced. For water-soluble vitamins, transporters such as SLC19A1 (folate) and SLC23A1 (ascorbate) can be downregulated at the transcriptional or post-transcriptional level. For iron, the divalent metal transporter SLC11A2 (DMT1) is regulated by iron-responsive elements (IREs) in its mRNA, which are bound by iron-regulatory proteins IRP1 (ACO1) and IRP2 (IREB2). When cellular iron is high, IRP binding is reduced, leading to decreased transporter synthesis.
Inhibition of basolateral export
In simple terms: Even if nutrients enter the gut cell, they can be blocked from leaving into the blood.
For iron, the basolateral exporter ferroportin (SLC40A1) is the target of hepcidin. Hepcidin binding to ferroportin induces its internalization and degradation, thereby preventing iron from entering the circulation. This mechanism effectively stops intestinal iron absorption at the exit step. Similar basolateral regulation may exist for other nutrients, though the molecular details are less defined.
Feedback loops and hormonal control
In simple terms: Hormones and feedback loops keep the whole system in balance.
Negative regulation of intestinal absorption is embedded in endocrine feedback loops. Hepcidin expression is controlled by iron stores, erythropoietic demand, and inflammation. Calcium absorption is regulated by calcitriol (1,25-dihydroxyvitamin D), which increases absorption, and by CASR, which can inhibit it when calcium is high. These loops ensure that absorption is tuned to physiological needs.
Microbial and dietary modulation
In simple terms: Gut bacteria and food components can also dial down absorption.
The gut microbiota can influence intestinal absorption. For example, Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease, potentially by modulating lipid absorption. Dietary components such as niacinamide may also affect absorption processes. These external factors add another layer of negative regulation.
Key Genes Involved in GO:1904479 negative regulation of intestinal absorption
The following genes and proteins are central to the negative regulation of intestinal absorption, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HAMP | Hormone hepcidin; binds ferroportin to block iron export | Master regulator of iron absorption; target for iron overload therapy |
| SLC40A1 | Ferroportin; basolateral iron exporter | Hepcidin target; mutations cause ferroportin disease |
| ACO1 | Iron-regulatory protein 1 (IRP1); binds IREs in transporter mRNAs | Post-transcriptional regulator of iron uptake |
| IREB2 | Iron-regulatory protein 2 (IRP2); regulates iron metabolism | Modulates DMT1 and other transporters |
| SLC11A2 | DMT1; apical iron transporter | Downregulated by IRP/IRE system |
| CASR | Calcium-sensing receptor; inhibits calcium absorption | Key sensor for calcium homeostasis |
| SLC19A1 | Folate transporter; reduced when folate is sufficient | Regulates water-soluble vitamin absorption |
| SLC23A1 | Ascorbate (vitamin C) transporter | Downregulated to prevent vitamin C overload |
| CD36 | Fatty acid translocase; involved in lipid absorption | Linked to immune responses and lipid uptake |
| NPC1L1 | Cholesterol uptake transporter | Target for cholesterol-lowering drugs |
| ABCG5 | Sterol efflux transporter; limits absorption | Promotes sterol excretion |
| ABCG8 | Sterol efflux transporter; heterodimer with ABCG5 | Limits dietary cholesterol absorption |
| FUT2 | Fucosyltransferase; affects gut microbiota and absorption | Modulates nutrient handling |
| MIR21 | MicroRNA; may regulate intestinal transporters | Potential post-transcriptional regulator |
| TJP1 | Tight junction protein ZO-1; affects paracellular absorption | Barrier function and absorption control |
| OCLN | Occludin; tight junction component | Paracellular permeability |
| CLDN1 | Claudin-1; tight junction protein | Regulates paracellular absorption |
How Is negative regulation of intestinal absorption Regulated?
Negative regulation of intestinal absorption is controlled by endocrine, paracrine, and intracellular signals. The hepcidin-ferroportin axis is the primary regulator of iron absorption: hepcidin expression is induced by iron loading, inflammation, and BMP/SMAD signaling, and hepcidin binding to ferroportin causes its degradation, blocking iron export. Calcium absorption is regulated by calcitriol and CASR; CASR activation can inhibit calcium transport when systemic calcium is high. Water-soluble vitamin transporters are regulated by substrate availability and cellular needs, often through transcriptional or post-transcriptional mechanisms. Additionally, the gut microbiota and dietary factors can modulate absorption; for example, Bacteroides uniformis-derived hexadecanedioic acid influences lipid metabolism. These regulatory layers ensure that absorption is adjusted to systemic demands.
negative regulation of intestinal absorption and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HAMP | Iron overload / hemochromatosis | HAMP knockout mice; hepcidin mimetics |
| SLC40A1 | Ferroportin disease | SLC40A1 knock-in mice; ferroportin degradation assays |
| CASR | Hypercalcemia / hypocalciuric hypercalcemia | CASR knockout mice; calcimimetic treatment |
| SLC19A1 | Folate deficiency / methotrexate response | SLC19A1 knockout Caco-2 cells; transport assays |
| CD36 | Metabolic syndrome / lipid absorption | CD36 knockout mice; lipid tolerance tests |
Iron overload disorders
Defects in negative regulation of intestinal iron absorption cause hereditary hemochromatosis and transfusional iron overload. Mutations in HAMP, HFE, or TFR2 lead to inadequate hepcidin production, resulting in excessive iron absorption and tissue damage. Therapies that mimic hepcidin or enhance its activity are under development.
Hypercalcemia and calcium disorders
Impaired negative regulation of calcium absorption can contribute to hypercalcemia, as seen in primary hyperparathyroidism or CASR mutations. CASR agonists (calcimimetics) are used to reduce calcium absorption and treat hypercalcemia.
Vitamin deficiencies and toxicities
Dysregulation of water-soluble vitamin transporters can lead to deficiencies (e.g., folate) or toxicities (e.g., vitamin C). Understanding negative regulation helps in designing supplementation strategies.
Metabolic-associated fatty liver disease (MAFLD)
Altered intestinal lipid absorption contributes to MAFLD. Microbial metabolites such as hexadecanedioic acid can ameliorate MAFLD by modulating absorption and metabolism. Targeting negative regulation of lipid absorption is a potential therapeutic strategy.
From negative regulation of intestinal absorption-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate iron absorption? | Hepcidin promoter reporter in HepG2 cells; ferroportin degradation assay |
| What is the role of CASR in calcium absorption? | CASR knockout mice; Ussing chamber calcium flux |
| How does SLC19A1 downregulation affect folate uptake? | SLC19A1 CRISPR knockout Caco-2 cells; folate transport assay |
| Does microbiota-derived metabolite affect lipid absorption? | Bacteroides uniformis colonization in mice; lipid absorption assay |
| Can a point mutation in SLC40A1 alter hepcidin sensitivity? | SLC40A1 knock-in mice; hepcidin challenge |
| What is the effect of CD36 overexpression on lipid uptake? | CD36 overexpression in Caco-2 cells; fatty acid uptake assay |
How to Study the negative regulation of intestinal absorption Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ussing chamber | Transepithelial flux of nutrients | Calcium and iron absorption |
| Caco-2 transport assay | Apical-to-basolateral transport | Vitamin and drug absorption |
| CRISPR knockout screen | Gene essentiality for absorption regulation | Identify negative regulators |
| RNA-seq | Transcriptional changes in transporters | Hepcidin or CASR signaling |
| Proteomics | Protein abundance and modifications | Ferroportin degradation |
| Mouse models | In vivo absorption and homeostasis | Iron overload, hypercalcemia |
| Microbiota analysis | Microbial composition and metabolites | MAFLD and lipid absorption |
| miRNA profiling | Post-transcriptional regulation | Ginger exosome effects on Caco-2 |
Transport assays
Transport assays using Caco-2 cell monolayers or Ussing chambers measure the rate of nutrient flux across intestinal epithelium. These assays can be used to test negative regulation by specific genes or treatments.
CRISPR screens
Genome-wide CRISPR knockout or activation screens in intestinal cell lines can identify genes that negatively regulate absorption of iron, calcium, or vitamins. Hits can be validated in secondary assays.
RNA-seq and proteomics
RNA sequencing and quantitative proteomics reveal changes in transporter expression upon negative regulation. For example, hepcidin treatment alters ferroportin protein levels.
Animal models
Mouse models with tissue-specific knockouts or knock-ins of key genes (e.g., HAMP, CASR) allow in vivo study of negative regulation of intestinal absorption.
How CRISPR Can Be Used to Study GO:1904479 negative regulation of intestinal absorption
Knockout
CRISPR knockout of candidate negative regulators (e.g., HAMP, CASR) in intestinal cell lines or mice can confirm their role in reducing absorption. For example, HAMP knockout mice exhibit increased iron absorption.
Point Mutation
Point mutations in transporters or sensors (e.g., SLC40A1, CASR) can mimic human disease variants and reveal how specific residues affect negative regulation. CRISPR base editing enables precise introduction of such mutations.
Knock-in
Knock-in of reporter genes (e.g., luciferase) or epitope tags into endogenous loci allows real-time monitoring of transporter expression and regulation. Tagged ferroportin knock-in mice are useful for tracking hepcidin-mediated degradation.
Overexpression
Overexpression of negative regulators (e.g., hepcidin, CASR) using CRISPR activation or lentiviral vectors can suppress absorption and serve as a therapeutic strategy. This approach is useful for validating targets in vivo.
How EDITGENE Supports negative regulation of intestinal absorption Research
Researchers studying negative regulation of intestinal absorption-related genes often need to determine whether a candidate gene is causally involved in reducing nutrient uptake, and to dissect the molecular mechanisms. EDITGENE provides comprehensive CRISPR gene editing services to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of intestinal absorption research.
Frequently Asked Questions About negative regulation of intestinal absorption
What is GO:1904479?
GO:1904479 is the Gene Ontology term for negative regulation of intestinal absorption, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of intestinal absorption.
What genes are involved in negative regulation of intestinal absorption?
Key genes include HAMP (hepcidin), SLC40A1 (ferroportin), CASR, ACO1, IREB2, SLC19A1, and SLC23A1, among others.
How does hepcidin negatively regulate iron absorption?
Hepcidin binds to ferroportin on intestinal cells, causing its internalization and degradation, which blocks iron export into the blood.
What diseases are linked to impaired negative regulation of intestinal absorption?
Iron overload disorders, hypercalcemia, vitamin deficiencies, and metabolic-associated fatty liver disease.
What experimental models are used to study GO:1904479?
Caco-2 cell transport assays, Ussing chambers, CRISPR knockout mice, and organoids are commonly used.
How can CRISPR help study negative regulation of intestinal absorption?
CRISPR knockout, knock-in, and activation allow precise manipulation of candidate genes to test their role in reducing absorption.
What is the role of CASR in calcium absorption?
CASR senses extracellular calcium and can inhibit calcium absorption when calcium levels are high, preventing hypercalcemia.
Can diet affect negative regulation of intestinal absorption?
Yes, dietary components and microbiota-derived metabolites can modulate absorption; for example, hexadecanedioic acid from Bacteroides uniformis affects lipid metabolism.
What methods measure intestinal absorption regulation?
Ussing chamber, Caco-2 transport assays, RNA-seq, proteomics, and animal models are standard methods.
Why is negative regulation of intestinal absorption important for drug development?
It helps prevent toxicity from excessive nutrient uptake and is a target for treating iron overload and hypercalcemia.
Conclusion
GO:1904479, negative regulation of intestinal absorption, is a critical biological process that maintains nutrient homeostasis and prevents toxicity. Key regulators such as hepcidin, ferroportin, and CASR have been well characterized, and their dysfunction leads to diseases like hemochromatosis and hypercalcemia. Advances in CRISPR gene editing and screening technologies are accelerating the discovery of new regulatory mechanisms. EDITGENE's services support researchers in dissecting these pathways with precision models.
References
- 1. Said HM. 2011. Intestinal absorption of water-soluble vitamins in health and disease.. Biochem J 437(3):357-72 PMID: 21749321
- 2. Ebea-Ugwuanyi PO et al.. 2024. Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.. Br J Haematol 204(3):759-773 PMID: 38253961
- 3. Ganz T. 2013. Systemic iron homeostasis.. Physiol Rev 93(4):1721-41 PMID: 24137020
- 4. Peacock M. 2010. Calcium metabolism in health and disease.. Clin J Am Soc Nephrol 5 Suppl 1:S23-30 PMID: 20089499
- 5. Zhang DY et al.. 2025. Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease.. Gut Microbes 17(1):2508433 PMID: 40413726
- 6. Cosmetic Ingredient Review Expert Panel. 2005. Final report of the safety assessment of niacinamide and niacin.. Int J Toxicol 24 Suppl 5:1-31 PMID: 16596767
- 7. Gao Y et al.. 2025. T cell cholesterol transport links intestinal immune responses to dietary lipid absorption.. Science 390(6769):eadt4169 PMID: 41066556
- 8. Yin L et al.. 2022. Characterization of the MicroRNA Profile of Ginger Exosome-like Nanoparticles and Their Anti-Inflammatory Effects in Intestinal Caco-2 Cells.. J Agric Food Chem 70(15):4725-4734 PMID: 35261246
